A role for p53 in terminal epithelial cell differentiation

被引:43
|
作者
Saifudeen, Z [1 ]
Dipp, S [1 ]
El-Dahr, SS [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2002年 / 109卷 / 08期
关键词
D O I
10.1172/JCI200213972
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Terminal epithelial cell differentiation is a crucial step in development. In the kidney, failure of terminal differentiation causes dysplasia, cystogenesis, and cancer. The present study provides multiple lines of evidence implicating the tumor suppressor protein p53 in terminal differentiation of the renal epithelium. In the developing kidney, p53 is highly enriched in epithehial cells expressing renal function genes (RFGs), such as receptors for vasoactive hormones, the sodium pump, and epithelial sodium and water channels. In comparison, proliferating renal progenitors express little if any p53 or RFGs. p53 binds to and transactivates the promoters of RFGs. In contrast, expression of a dominant negative mutant form of p53 inhibits endogenous RFG expression. Moreover, binding of endogenous p53 to the promoters of RFGs coincides with the differentiation process and is attenuated once renal epithelial cells are fully differentiated. Finally, p53-null pups exhibit a previously unrecognized aberrant renal phenotype and spatial disorganization of RFGs. Interestingly, the p53-related protein p73 is unable to functionally compensate for the loss of p53 and fails to efficiently activate RFG transcription. We conclude that p53 promotes the biochemical and morphological differentiation of the renal epithelium. Aberrations in p53-mediated terminal differentiation may therefore play a role in the pathogenesis of nephron dysgenesis and dysfunction.
引用
收藏
页码:1021 / 1030
页数:10
相关论文
共 50 条
  • [41] Pro-survival role of p53 in regulating epidermal differentiation
    Kracikova, Martina
    Akiri, Gal
    Aaronson, Stuart A.
    CANCER RESEARCH, 2013, 73
  • [42] The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome
    Malkin, D
    Brown, EJ
    Zipursky, A
    CANCER GENETICS AND CYTOGENETICS, 2000, 116 (01) : 1 - 5
  • [43] p53 Protein expression and p53 mutation in thymic epithelial tumors - Reply
    Tateyama, H
    Eimoto, T
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 105 (05) : 658 - 658
  • [44] P53 MUTATIONS IN HUMAN IMMORTALIZED EPITHELIAL-CELL LINES
    LEHMAN, TA
    MODALI, R
    BOUKAMP, P
    STANEK, J
    BENNETT, WP
    WELSH, JA
    METCALF, RA
    STAMPFER, MR
    FUSENIG, N
    ROGAN, EM
    HARRIS, CC
    CARCINOGENESIS, 1993, 14 (05) : 833 - 839
  • [45] Cell proliferation and p53 protein expression in cutaneous epithelial neoplasms
    Onodera, H
    Nakamura, S
    Sugai, T
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1996, 18 (06) : 580 - 588
  • [46] The role of retinoblastoma and p53 tumor suppressor pathways in human mammary epithelial cell immortalization (Review)
    Band, V
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (03) : 499 - 507
  • [47] Influenza virus infection increases p53 activity: Role of p53 in cell death and viral replication
    Turpin, E
    Luke, M
    Jones, J
    Tumpey, T
    Konan, K
    Schultz-Cherry, S
    JOURNAL OF VIROLOGY, 2005, 79 (14) : 8802 - 8811
  • [48] A Novel Small Molecule p53 Stabilizer for Brain Cell Differentiation
    Amaral, Joana D.
    Silva, Dario
    Rodrigues, Cecilia M. P.
    Sola, Susana
    Santos, Maria M. M.
    FRONTIERS IN CHEMISTRY, 2019, 7
  • [49] Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity
    Jiang, M
    Yi, XL
    Hsu, S
    Wang, CY
    Dong, Z
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (06) : F1140 - F1147
  • [50] Regulation of ES cell differentiation by functional and conformational modulation of p53
    Sabapathy, K
    Klemm, M
    Jaenisch, R
    Wagner, EF
    EMBO JOURNAL, 1997, 16 (20): : 6217 - 6229